NCT01190657已完成4 期
A Multiple-center, Self-controlled Open Study to Evaluate Efficacy and Safety of Teprenone in Patients With Acute Gastritis, Acute Gastric Lesion of Chronic Gastritis With Acute Exacerbation or Gastric Ulcer
适应症
干预措施
相关药物
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 入组人数
- 1,184
- 试验地点
- 26
- 主要终点
- Endoscopic results of ulcer lesion
研究概览
简要总结
This is a self-controlled, open, multiple-center clinical trial.
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
研究组 & 干预措施
Selbex 50mg (14 days)
Experimental
干预措施: Selbex (Drug)
Selbex 50mg (56 days)
Experimental
干预措施: Selbex (Drug)
结局指标
主要结局
Endoscopic results of ulcer lesion
时间窗: 56 days
Heal rate = (healed cases + significant improved cases)/total cases administered ×100 %
Total effective rate
时间窗: 56 days.
Total effective rate = (healed cases + significant improved cases + effective cases)/total cases administered ×100 %.
次要结局
- Symptoms improved level(56 days)
研究者
研究点 (26)
Loading locations...
相似试验
已完成
不适用
Evaluating the Effectiveness and Safety of Colon Capsule Endoscope System for Capturing and Viewing Colon ImagesProspective StudyNCT05308511Wuhan Union Hospital, China128
招募中
2 期
TAS-102 Combined With Bevacizumab for Second-line Maintenance Treatment of Advanced Colorectal CancerColorectal CancerNCT06293014Henan Cancer Hospital224
尚未招募
2 期
Chidamide Combined With Exemestane (+/- Goserelin) Versus Neoadjuvant Chemotherapy in Patients of Stage II-III HR-positive/HER2-negative Breast CancerBreast NeoplasmsNCT05253066Shengjing Hospital130
Unknown
不适用
Efficacy and Safety of PEG-rhG-CSF in the Prevention of Neutropenia After Chemo in Pts With Gynecological MalignanciesGynecologic Malignant TumorNCT04773327Xiaohua Wu MD150
招募中
2 期
Perioperative Tislelizumab Combined With Nab-Paclitaxel for Muscle-invasive Urothelial Bladder Cancer: A Multicenter StudyMuscle Invasive Bladder Cancer Urothelial CarcinomaNCT05328336Tianjin Medical University Second Hospital74
